Search
Now showing items 1-2 of 2
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
(Frontiers in Physiology, 2019-08-13)
Background: The dual Na+ and cardiac Ca2+-release channel inhibitor, Flecainide (FLEC) is effective in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), a disease caused by mutations in cardiac ...
Neuronal and hormonal perturbations in postural tachycardia syndrome (vol 5, 220, 2014)
(Frontiers in Physiology, 2019-07-30)
[This corrects the article DOI: 10.3389/fphys.2014.00220.]. http://hdl.handle.net/1803/10006